Reports Q3 revenue $118.1M, consensus $109.78M. "Accuray delivered strong revenue and EBITDA growth in the third quarter driven by growing global demand for our advanced radiotherapy solutions," said CEO Suzanne Winter. "Our teams are laser focused on making meaningful progress against our long-term strategic goals. We believe our investments in technology innovation, focus on operational discipline and strategic partnerships, matched with a best-in-class team, will enable us to transform radiotherapy care and bring value to patients and healthcare providers worldwide."
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ARAY: